Sharekhan

NSE

BSE

iSERA Lifesciences Ltd

Thu 10/09/2026,16:1:0 | BSE : ISERA

₹143.900.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 143.90

Previous Close

₹ 143.90

Volume

200

Mkt Cap ( ₹ Cr)

₹ 121.01

High

₹ 143.90

Low

₹ 143.90

52 Week High

₹ 143.90

52 Week Low

₹ 7.99

Book Value Per Share

₹ 9.41

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

TTM EPS

-0.07

TTM PE

-2055.71

P/B

15.29

What's Your Call?

CollectiveÂ community sentiment on iSERA Lifesciences Ltd

Your Vote -

Buy

58.33%

Hold

33.33%

Sell

8.33%

58.33%

12 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts iSERA Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

iSERA Lifesciences - Reg. 34 (1) Annual Report.

5 Sep 2026, 7:30PM we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financ
iSERA Lifesciences - Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technolog

5 Sep 2026, 7:14PM Notice of 34th Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, September 29, 2026 at 3:00 P.M. (IST) through video c
iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of S

1 Sep 2026, 4:05PM We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewi
iSERA Lifesciences - Submission Of Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences

14 Aug 2026, 10:50PM We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Tech
iSERA Lifesciences - Un-Audited Financial Results For The Quarter Ended June 30, 2026

7 Aug 2026, 2:49PM We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
iSERA Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026 Under Regulation 30 Of SEBI\r\

7 Aug 2026, 2:39PM Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure\r\nRequirements), Regulations 2015, the Board of Directors
iSERA Lifesciences - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be H

3 Aug 2026, 12:32PM Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider a
iSERA Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

20 Jul 2026, 8:10PM As of June 2026, 58.63% is owned by Indian Promoters and 41.37% by Public. <p align=justify> Top five Promoters holding highest number of shares of iS
iSERA Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

14 Jul 2026, 12:35PM We are hereby submitting the Certificate issued by Share Transfer Agent of the Company, confirming compliance with Regulation 74(5) of SEBI (Depositor
iSERA Lifesciences - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

29 Jun 2026, 7:08PM Scrutinizer's Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot No
iSERA Lifesciences - Filing Of Corrigendum To The Notice Of Postal Ballot Dated April 21, 2026 Of Isera Lifesciences Limited

26 Jun 2026, 5:57PM We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh Technologies\r\nLimited) has issued a Corrigendum to the Notice of Pos

Key fundamentals

Evaluate the intrinsic value of iSERA Lifesciences Ltd stockÂ

Name	March-26	March-25	March-24	March-23	March-22
Assets	8.2471	1.5076	-0.0307	0.0088	-0.0045
Liabilities	8.2471	1.5076	-0.0307	0.0088	-0.0045
Equity	8.409	0.3234	0.3234	0.3	0
Gross Profit	0.2662	-0.1262	-0.0988	-0.1163	-0.1055
Net Profit	0.2594	0.139	-0.0988	-0.1117	-0.1055
Cash From Operating Activities	-5.2974	-1.4017	-0.0606	-0.1233	-0.3
NPM(%)	19.14	0	0	0	0
Revenue	1.355	0	0	0	0
Expenses	1.0888	0.1262	0.0988	0.1163	0.1055
ROE(%)	3.27	1.75	-1.24	-1.41	-1.33

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	11.00	0.32	323422.00	10	0.32
2023	2024	Equity Share	11.00	0.32	323422.00	10	0.32
2022	2023	Equity Share	11.00	0.30	300000.00	10	0.30
2021	2022	Equity Share	11.00	10.60	10600000.00	10	10.60
2020	2021	Equity Share	11.00	10.60	10600000.00	10	10.60
2019	2020	Equity Share	11.00	10.60	10600000.00	10	10.60
2017	2018	Equity Share	11.00	10.60	10600000.00	10	10.60
2016	2017	Equity Share	11.00	10.60	10600000.00	10	10.60
2015	2016	Equity Share	11.00	10.60	10600000.00	10	10.60
2014	2015	Equity Share	11.00	10.60	10600000.00	10	10.60
2013	2014	Equity Share	11.00	10.60	10600000.00	10	10.60
2012	2013	Equity Share	11.00	10.60	10600000.00	10	10.60
2011	2012	Equity Share	4.00	3.60	3600000.00	10	3.60
2010	2011	Equity Share	4.00	3.60	3600000.00	10	3.60
2009	2010	Equity Share	4.00	3.60	3600000.00	10	3.60
2008	2009	Equity Share	4.00	3.60	3600000.00	10	3.60
2007	2008	Equity Share	4.00	3.60	3600000.00	10	3.60

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to iSERA Lifesciences Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Prodocs Solutions Ltd	151.20	0.00	10.24	78.43	147.72	0.00
Tata Consultancy Services Ltd	2202.00	-0.65	15.99	52091.80	13601.11	5.00
Accelya Solutions India Ltd	1119.55	0.03	17.50	214.80	639.00	0.00
Allied Digital Services Ltd	99.00	0.41	15.21	813.32	101.71	1.50

Company Info

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

2012 -Company has changed its name from Lordven Technologies Ltd. to Aptus Industries Ltd. 2013 -M/s. Netocol Systems and Solutions Private Limited - a subsidiary has been amalgamated with Aptus Industries Ltd. (Covidh Technologies Ltd.) 2014 -Mr. UdayChava has been appointed as Executive Vice President of the Company. -Registered Office of the Company has been changed from "501MCR Complex, Sri Swamy Ayyappa Co - Op Housing Society, Madhapur, Hyderabad, Andhra Pradesh - 500081" to "1st Floor, Plot No. 450, Road No. 19, Jubilee Hills, Hyderabad, Andhra Pradesh - 500033." -Company has changed its name from Aptus Industries Ltd to Covidh Technologies Ltd. 2016 -Registered office of the company has changed from Plot No.458, 1st floor, Road No. 19, Jubilee Hills, Hyderabad, Telangana - 500033 to Plot No.458, Ground floor, Road No.19, Jubilee Hills, Hyderabad, Telangana-500033. 2025 -The company issued rights shares of Rs. 10 in the ratio of 25:1 at par.

Read More

Parent Organisation

iSERA Lifesciences Ltd.

Founded

27/01/1993

Managing Director

Mrs.Jayshree Suresh Jain

NSE Symbol

FAQ

OPEN FREE* DEMAT ACCOUNT